Aspira Women’s Health Inc. (NASDAQ:AWH) Sees Significant Growth in Short Interest

Aspira Women’s Health Inc. (NASDAQ:AWH – Get Rating) was the target of a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 104,900 shares, an increase of 58.9% from the April 30th total of 66,000 shares. Currently, 2.3% of the shares of the stock are sold short. Based on an average daily volume of 21,600 shares, the short-interest ratio is presently 4.9 days.

Wall Street Analysts Forecast Growth

Separately, StockNews.com initiated coverage on shares of Aspira Women’s Health in a research report on Tuesday. They issued a “sell” rating for the company.

Aspira Women’s Health Stock Down 6.4 %

Shares of Aspira Women’s Health stock traded down $0.24 during trading hours on Friday, reaching $3.50. The company’s stock had a trading volume of 23,125 shares, compared to its average volume of 20,852. Aspira Women’s Health has a one year low of $3.26 and a one year high of $16.50. The company has a market capitalization of $29.16 million, a P/E ratio of -0.27 and a beta of 2.93. The stock’s fifty day simple moving average is $5.79 and its two-hundred day simple moving average is $6.31. The company has a debt-to-equity ratio of 2.67, a quick ratio of 1.73 and a current ratio of 1.78.

Aspira Women’s Health (NASDAQ:AWH – Get Rating) last released its quarterly earnings data on Wednesday, March 22nd. The company reported ($0.60) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.90) by $0.30. Aspira Women’s Health had a negative net margin of 278.48% and a negative return on equity of 291.79%. The firm had revenue of $2.15 million for the quarter, compared to analyst estimates of $2.40 million. On average, research analysts forecast that Aspira Women’s Health will post -2.04 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. Atria Wealth Solutions Inc. purchased a new stake in Aspira Women’s Health during the first quarter worth about $49,000. JPMorgan Chase & Co. increased its holdings in Aspira Women’s Health by 126.3% during the first quarter. JPMorgan Chase & Co. now owns 64,839 shares of the company’s stock worth $67,000 after buying an additional 36,189 shares during the last quarter. Sawtooth Solutions LLC increased its holdings in Aspira Women’s Health by 144.6% during the first quarter. Sawtooth Solutions LLC now owns 67,983 shares of the company’s stock worth $71,000 after buying an additional 40,195 shares during the last quarter. Private Advisor Group LLC increased its holdings in Aspira Women’s Health by 361.8% during the first quarter. Private Advisor Group LLC now owns 69,697 shares of the company’s stock worth $73,000 after buying an additional 54,603 shares during the last quarter. Finally, Baker Tilly Wealth Management LLC increased its holdings in Aspira Women’s Health by 150.8% during the first quarter. Baker Tilly Wealth Management LLC now owns 74,560 shares of the company’s stock worth $27,000 after buying an additional 44,834 shares during the last quarter. 10.63% of the stock is owned by institutional investors.

About Aspira Women’s Health

(Get Rating)

Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.